MedPath

AFFECT THERAPEUTICS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder

Not Applicable
Completed
Conditions
Methamphetamine Abuse
Interventions
Behavioral: Affect Methamphetamine Treatment Program
First Posted Date
2022-03-04
Last Posted Date
2022-03-04
Lead Sponsor
Affect Therapeutics, Inc.
Target Recruit Count
79
Registration Number
NCT05266716
Locations
🇺🇸

Affect Therapeutics, New York, New York, United States

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

Not Applicable
Completed
Conditions
Methamphetamine Abuse
Interventions
Other: Affect Treatment Program for Methamphetamine Use Disorder
First Posted Date
2022-01-25
Last Posted Date
2023-01-11
Lead Sponsor
Affect Therapeutics, Inc.
Target Recruit Count
100
Registration Number
NCT05206175
Locations
🇺🇸

Affect Therapeutics, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath